112 related articles for article (PubMed ID: 8446657)
1. Protective effect of diclofenac sodium against endotoxic shock in anaesthetized pigs.
Mózes T; Heiligers JP; Tak CJ; Zijlstra FJ; Ben-Efraim S; Saxena PR; Bonta IL
Prostaglandins Leukot Essent Fatty Acids; 1993 Feb; 48(2):193-200. PubMed ID: 8446657
[TBL] [Abstract][Full Text] [Related]
2. Sequential release of tumour necrosis factor, platelet activating factor and eicosanoids during endotoxin shock in anaesthetized pigs: protective effects of indomethacin.
Mózes T; Zijlstra FJ; Heiligers JP; Tak CJ; Ben-Efraim S; Bonta IL; Saxena PR
Br J Pharmacol; 1991 Nov; 104(3):691-9. PubMed ID: 1797328
[TBL] [Abstract][Full Text] [Related]
3. Platelet activating factor is one of the mediators involved in endotoxic shock in pigs.
Mózes T; Heiligers JP; Tak CJ; Zijlstra FJ; Ben-Efraim S; Saxena PR; Bonta IL
J Lipid Mediat; 1991 Nov; 4(3):309-25. PubMed ID: 1764577
[TBL] [Abstract][Full Text] [Related]
4. Sequential release of eicosanoids during endotoxin-induced shock in anesthetized pigs.
Mózes T; Zijlstra FJ; Heiligers JP; Saxena PR; Bonta IL
Prostaglandins Leukot Essent Fatty Acids; 1991 Apr; 42(4):209-16. PubMed ID: 1651510
[TBL] [Abstract][Full Text] [Related]
5. Interactions between platelet activating factor and eicosanoids during endotoxic shock in anaesthetized pigs.
Mózes T; Zijlstra FJ; Heiligers JP
Mediators Inflamm; 1992; 1(3):183-90. PubMed ID: 18475459
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of tumor necrosis factor determine the fatal or non-fatal course of endotoxic shock.
Mózes T; Ben-Efraim S; Tak CJ; Heiligers JP; Saxena PR; Bonta IL
Immunol Lett; 1991 Feb; 27(2):157-62. PubMed ID: 2026458
[TBL] [Abstract][Full Text] [Related]
7. Lethal and non-lethal course of endotoxic shock is determined by interactions between tumor necrosis factor, platelet activating factor and eicosanoids.
Mozes T; Ben-Efraim S; Bonta IL
Pathol Biol (Paris); 1992 Oct; 40(8):807-12. PubMed ID: 1484741
[TBL] [Abstract][Full Text] [Related]
8. Time course of various inflammatory mediators during recurrent endotoxemia.
Klosterhalfen B; Hörstmann-Jungemann K; Vogel P; Flohé S; Offner F; Kirkpatrick CJ; Heinrich PC
Biochem Pharmacol; 1992 May; 43(10):2103-9. PubMed ID: 1599496
[TBL] [Abstract][Full Text] [Related]
9. Platelet-activating factor and arachidonic acid metabolites mediate tumor necrosis factor and eicosanoid kinetics and cardiopulmonary dysfunction during bacteremic shock.
Quinn JV; Slotman GJ
Crit Care Med; 1999 Nov; 27(11):2485-94. PubMed ID: 10579269
[TBL] [Abstract][Full Text] [Related]
10. Effects of the endothelin receptor antagonist, SB 209670, on circulatory failure and organ injury in endotoxic shock in the anaesthetized rat.
Ruetten H; Thiemermann C; Vane JR
Br J Pharmacol; 1996 May; 118(1):198-204. PubMed ID: 8733596
[TBL] [Abstract][Full Text] [Related]
11. Complement depletion with Naje haje cobra venom factor limits prostaglandin release and improves visceral perfusion in porcine endotoxic shock.
Fink MP; Rothschild HR; Deniz YF; Cohn SM
J Trauma; 1989 Aug; 29(8):1076-84; discussion 1084-5. PubMed ID: 2668544
[TBL] [Abstract][Full Text] [Related]
12. Lack of effect of TNF antibodies on the cardiovascular sequelae of lipopolysaccharide infusion in conscious rats.
Waller J; Gardiner SM; Jose J; Bennett T
Br J Pharmacol; 1995 Nov; 116(5):2487-95. PubMed ID: 8581289
[TBL] [Abstract][Full Text] [Related]
13. The endothelin receptor antagonist, bosentan, in combination with the cyclooxygenase inhibitor, diclofenac, counteracts pulmonary hypertension in porcine endotoxin shock.
Wanecek M; Rudehill A; Hemsén A; Lundberg JM; Weitzberg E
Crit Care Med; 1997 May; 25(5):848-57. PubMed ID: 9187606
[TBL] [Abstract][Full Text] [Related]
14. Cardiopulmonary and splanchnic blood flow during 48 hours of a continuous infusion of endotoxin in conscious pigs: a model of hyperdynamic shock.
Murphey ED; Traber DL
Shock; 2000 Mar; 13(3):224-9. PubMed ID: 10718380
[TBL] [Abstract][Full Text] [Related]
15. Role of platelet-activating factor and eicosanoids during endotoxin-induced lung injury in pigs.
Olson NC; Joyce PB; Fleisher LN
Am J Physiol; 1990 Jun; 258(6 Pt 2):H1674-86. PubMed ID: 2163217
[TBL] [Abstract][Full Text] [Related]
16. Effect of 5-lipoxygenase and cyclooxygenase blockade on porcine hemodynamics during continuous infusion of platelet-activating factor.
Olson NC; Kruse-Elliott KT; Johnson LW
Prostaglandins Leukot Essent Fatty Acids; 1993 Aug; 49(2):549-59. PubMed ID: 8415804
[TBL] [Abstract][Full Text] [Related]
17. Role for intracellular platelet-activating factor in the circulatory failure in a model of gram-positive shock.
De Kimpe SJ; Thiemermann C; Vane JR
Br J Pharmacol; 1995 Dec; 116(8):3191-8. PubMed ID: 8719795
[TBL] [Abstract][Full Text] [Related]
18. Differences in eicosanoid and cytokine production between injury/hemorrhage and bacteremic shock in the pig.
Foëx BA; Quinn JV; Little RA; Shelly MP; Slotman GJ
Shock; 1997 Oct; 8(4):276-83. PubMed ID: 9329129
[TBL] [Abstract][Full Text] [Related]
19. Platelet activating factor mediates cardiopulmonary dysfunction during graded bacteremic shock.
Woolley DS; Puglisi RN; Quinn JV; Slotman GJ
J Trauma; 1996 Aug; 41(2):291-6; discussion 296-7. PubMed ID: 8760539
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment with tumor necrosis factor-alpha attenuates arterial hypotension and mortality induced by endotoxin in pigs.
Murphey ED; Traber DL
Crit Care Med; 2000 Jun; 28(6):2015-21. PubMed ID: 10890657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
